# Clinical trials recruiting in Maine: 200 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 200 trials recruiting or not yet recruiting with a site in Maine, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Maine: 200 rows for $10, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/maine

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 200
- Recruiting or not yet: 200
- Read on: November 19, 2026

## Trials

The 25 newest of 200, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 29, 2026 | NCT07846657 | ITM vs ITM+Clonidine for Lumbar Fusions | MaineHealth | Phase 3 | Not yet recruiting | Lumbar Fusion Surgery | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846657) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| July 20, 2026 | NCT07713979 | VisionWay Accessibility | Ohio State University | Not applicable | Recruiting | Persons With Visual Disabilities | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07713979) |
| July 2, 2026 | NCT07680244 | (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000 | Sponsor not shown (see the record) | Not applicable | Recruiting | Epiretinal Membrane, Dry Age Related Macular Degeneration, Macular Abnormalities, Retina Disease, Vitreoretinal... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680244) |
| June 30, 2026 | NCT07676565 | Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study | Indiana University | Observational | Recruiting | Type 1 Diabetes | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676565) |
| May 28, 2026 | NCT07611110 | AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) | AstraZeneca | Phase 3 | Recruiting | Metastatic Castration-resistant Prostate Cancer | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07611110) |
| May 18, 2026 | NCT07592858 | Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study | University of Rhode Island | Phase 2 | Not yet recruiting | PFAS, Environmental Exposures, Occupational Exposure to Chemicals, Military Exposure, Burn Pit Exposure, Forever... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592858) |
| May 18, 2026 | NCT07592273 | Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved... | AbbVie | Phase 2/3 | Recruiting | Diabetic Retinopathy | 576 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592273) |
| May 12, 2026 | NCT07582432 | A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency... | Grifols Biologicals, LLC | Phase 3 | Recruiting | Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582432) |
| May 5, 2026 | NCT07567001 | A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Heart Failure | 5,610 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567001) |
| May 1, 2026 | NCT07561593 | Improving Health Outcomes Through Investigations of Wabanaki Food Systems in Maine | Wabanaki Public Health and Wellness | Not applicable | Recruiting | Food Insecurity | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561593) |
| March 30, 2026 | NCT07500506 | A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine | Pfizer | Phase 3 | Recruiting | Lyme Disease | 1,712 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07500506) |
| March 27, 2026 | NCT07496567 | A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) | EyeBiotech Ltd. | Phase 2/3 | Recruiting | Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Wet Macular Degeneration | 960 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07496567) |
| March 12, 2026 | NCT07466316 | A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount... | Children's Oncology Group | Phase 3 | Recruiting | Rhabdomyosarcoma | 342 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07466316) |
| March 4, 2026 | NCT07450547 | Phase 2 Study to Assess the Safety and Efficacy of ANG003 | Anagram Therapeutics, Inc. | Phase 2 | Recruiting | Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | 113 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07450547) |
| March 2, 2026 | NCT07441681 | Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin | NRG Oncology | Phase 3 | Recruiting | Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally Advanced Laryngeal Squamous Cell Carcinoma, Locally... | 454 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07441681) |
| February 23, 2026 | NCT07428538 | Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) | Bausch Health Americas, Inc. | Phase 3 | Recruiting | Hepatitis | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428538) |
| February 11, 2026 | NCT07403721 | AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors | Amgen | Phase 1 | Recruiting | Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair... | 464 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07403721) |
| February 6, 2026 | NCT07391774 | Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the... | National Cancer Institute (NCI) | Phase 3 | Recruiting | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer... | 1,978 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07391774) |
| January 23, 2026 | NCT07363694 | A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease | Pfizer | Phase 2/3 | Recruiting | Moderate to Severe Chronic Obstructive Pulmonary Disease | 1,156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363694) |
| January 8, 2026 | NCT07326566 | Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII | Black Diamond Therapeutics, Inc. | Phase 2 | Recruiting | Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM, Glioblastoma Multiforme (GBM), Glioma, Central Nervous System... | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07326566) |
| January 7, 2026 | NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL | Alliance for Clinical Trials in Oncology | Phase 3 | Recruiting | Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia | 466 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321652) |
| January 6, 2026 | NCT07318558 | A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Ovarian Neoplasms, Ovarian Cancer | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318558) |
| December 19, 2025 | NCT07293247 | A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment | Alliance for Clinical Trials in Oncology | Phase 2 | Recruiting | Lung Non-Small Cell Carcinoma | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07293247) |
| December 18, 2025 | NCT07291037 | Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC... | AstraZeneca | Phase 3 | Recruiting | Non-small Cell Lung Cancer (NSCLC) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07291037) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| MaineHealth Maine Medical Center- Scarborough | Scarborough | 39 |
| MaineHealth Cancer Care and IV Therapy - South Portland | South Portland | 30 |
| Maine Children's Cancer Program | Scarborough | 25 |
| MaineHealth Cancer Care Center of York County | Sanford | 23 |
| Lafayette Family Cancer Center-EMMC | Brewer | 22 |
| MaineHealth Maine Medical Center - Portland | Portland | 22 |
| Maine Medical Center | Portland | 21 |
| New England Cancer Specialists | Scarborough | 20 |
| Harold Alfond Center for Cancer Care | Augusta | 19 |
| Eastern Maine Medical Center | Bangor | 17 |
| MaineHealth Cancer Care and IV Therapy - Brunswick | Brunswick | 15 |
| MaineHealth Cancer Care and IV Therapy - Sanford | Sanford | 11 |
| MaineHealth Coastal Cancer Treatment Center | Bath | 11 |
| Penobscot Bay Medical Center | Rockport | 10 |
| MaineHealth Maine Medical Center - Biddeford | Biddeford | 9 |
| MaineHealth LincolnHealth Hospital | Damariscotta | 9 |
| MaineHealth Waldo Hospital | Belfast | 8 |
| Mid Coast Hospital | Brunswick | 7 |
| Maine Eye Center | Portland | 4 |
| Northern Light Eastern Maine Medical Center | Bangor | 4 |
| MaineHealth Stephens Hospital | Norway | 3 |
| Maine Medical Partners Pediatric Specialty Care | Portland | 3 |
| MaineHealth Institute for Research | South Portland | 3 |
| MaineHealth Maine Medical Center | Portland | 2 |
| Maine Medical Center - Scarborough Campus | Scarborough | 2 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 1 |
| Phase 1/2 | 6 |
| Phase 2 | 36 |
| Phase 2/3 | 12 |
| Phase 3 | 89 |
| Phase 4 | 6 |
| Not applicable | 21 |
| Observational | 29 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Lung Neoplasms | 12 |
| Leukemia, Myeloid, Acute | 10 |
| Ovarian Neoplasms | 9 |
| Neoplasm Metastasis | 9 |
| Endometrial Neoplasms | 8 |
| Neoplasms | 7 |
| Prostatic Neoplasms | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Colonic Neoplasms | 6 |
| Heart Failure | 5 |
| Atrial Fibrillation | 5 |
| Carcinoma | 5 |
| Carcinoma, Renal Cell | 5 |
| Melanoma | 5 |
| Multiple Myeloma | 4 |
| Myeloproliferative Disorders | 4 |
| Myelodysplastic Syndromes | 4 |
| Colorectal Neoplasms | 4 |
| Burkitt Lymphoma | 4 |
| Cardiovascular Diseases | 4 |
| Fallopian Tube Neoplasms | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Rectal Neoplasms | 4 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 25 |
| Children's Oncology Group | 15 |
| NRG Oncology | 11 |
| Alliance for Clinical Trials in Oncology | 10 |
| SWOG Cancer Research Network | 9 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 8 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 7 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 4 |
| Dana-Farber Cancer Institute | 4 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 4 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 3 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 3 |
| Duke University | 3 |
| Yale University | 2 |
| MaineHealth | 2 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 2 |
| ECOG-ACRIN Cancer Research Group | 2 |
| Alliance Foundation Trials, LLC. | 2 |
| [Medtronic Cardiovascular](https://specstream.ai/data/clinical-trials/company/medtronic-cardiovascular) | 2 |
| Johns Hopkins University | 2 |
| American Society of Clinical Oncology | 2 |
| Travere Therapeutics, Inc. | 2 |
| Wake Forest University Health Sciences | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Maine

- [Mortgage brokers in Maine, United States](https://specstream.ai/data/businesses/mortgage-brokers/maine-united-states)
- [Propane suppliers in Maine, United States](https://specstream.ai/data/businesses/propane-suppliers/maine-united-states)
- [Tax preparation firms in Maine, United States](https://specstream.ai/data/businesses/tax-preparation-firms/maine-united-states)
- [Art schools in Maine, United States](https://specstream.ai/data/businesses/art-schools/maine-united-states)
- [Carpet cleaning companies in Maine, United States](https://specstream.ai/data/businesses/carpet-cleaning-companies/maine-united-states)
- [Driving schools in Maine, United States](https://specstream.ai/data/businesses/driving-schools/maine-united-states)
